
Gilead’s COVID-19 drug helps boost 2nd-quarter results as HIV sales dip By Reuters
© Reuters. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of […]